162 related articles for article (PubMed ID: 33629812)
1. Xanthohumol Microbiome and Signature in Healthy Adults (the XMaS Trial): Safety and Tolerability Results of a Phase I Triple-Masked, Placebo-Controlled Clinical Trial.
Langley BO; Ryan JJ; Hanes D; Phipps J; Stack E; Metz TO; Stevens JF; Bradley R
Mol Nutr Food Res; 2021 Apr; 65(8):e2001170. PubMed ID: 33629812
[TBL] [Abstract][Full Text] [Related]
2. Xanthohumol microbiome and signature in healthy adults (the XMaS trial): a phase I triple-masked, placebo-controlled clinical trial.
Bradley R; Langley BO; Ryan JJ; Phipps J; Hanes DA; Stack E; Jansson JK; Metz TO; Stevens JF
Trials; 2020 Oct; 21(1):835. PubMed ID: 33028396
[TBL] [Abstract][Full Text] [Related]
3. Xanthohumol microbiome and signature in adults with Crohn's disease (the XMaS trial): a protocol for a phase II triple-masked, placebo-controlled clinical trial.
Langley BO; Ryan JJ; Phipps J; Buttolph L; Bray B; Aslan JE; Metz TO; Stevens JF; Bradley R
Trials; 2022 Oct; 23(1):885. PubMed ID: 36273173
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability and Cardiometabolic Effects of Xanthohumol: Evidence from Animal and Human Studies.
Neumann HF; Frank J; Venturelli S; Egert S
Mol Nutr Food Res; 2022 Mar; 66(6):e2100831. PubMed ID: 34967501
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological profile of xanthohumol, a prenylated flavonoid from hops (Humulus lupulus).
Liu M; Hansen PE; Wang G; Qiu L; Dong J; Yin H; Qian Z; Yang M; Miao J
Molecules; 2015 Jan; 20(1):754-79. PubMed ID: 25574819
[TBL] [Abstract][Full Text] [Related]
6. Correction to: Xanthohumol microbiome and signature in healthy adults (the XMaS trial): a phase I triple-masked, placebo-controlled clinical trial.
Bradley R; Langley BO; Ryan JJ; Phipps J; Hanes DA; Stack E; Jansson JK; Metz TO; Stevens JF
Trials; 2020 Oct; 21(1):885. PubMed ID: 33106168
[TBL] [Abstract][Full Text] [Related]
7. Xanthohumol lowers body weight and fasting plasma glucose in obese male Zucker fa/fa rats.
Legette LL; Luna AY; Reed RL; Miranda CL; Bobe G; Proteau RR; Stevens JF
Phytochemistry; 2013 Jul; 91():236-41. PubMed ID: 22640929
[TBL] [Abstract][Full Text] [Related]
8. Gut enterotype-dependent modulation of gut microbiota and their metabolism in response to xanthohumol supplementation in healthy adults.
Jamieson PE; Smart EB; Bouranis JA; Choi J; Danczak RE; Wong CP; Paraiso IL; Maier CS; Ho E; Sharpton TJ; Metz TO; Bradley R; Stevens JF
Gut Microbes; 2024; 16(1):2315633. PubMed ID: 38358253
[TBL] [Abstract][Full Text] [Related]
9. Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.
Perry MS
Epilepsy Curr; 2019; 19(2):93-95. PubMed ID: 30955420
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics, pharmacodynamics, safety, and tolerability of single-dose denosumab in healthy Chinese volunteers: A randomized, single-blind, placebo-controlled study.
Chen Q; Hu C; Liu Y; Song R; Zhu W; Zhao H; Nino A; Zhang F; Liu Y
PLoS One; 2018; 13(6):e0197984. PubMed ID: 29933364
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the anxiolytic effects of xanthohumol, a component of humulus lupulus (Hops), in the male Sprague-Dawley rat.
Ceremuga TE; Johnson LA; Adams-Henderson JM; McCall S; Johnson D
AANA J; 2013 Jun; 81(3):193-8. PubMed ID: 23923669
[TBL] [Abstract][Full Text] [Related]
12. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
Kisicki JC; Fiske K; Lyne A
Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
[TBL] [Abstract][Full Text] [Related]
13. A safety study of oral tangeretin and xanthohumol administration to laboratory mice.
Vanhoecke BW; Delporte F; Van Braeckel E; Heyerick A; Depypere HT; Nuytinck M; De Keukeleire D; Bracke ME
In Vivo; 2005; 19(1):103-7. PubMed ID: 15796161
[TBL] [Abstract][Full Text] [Related]
14. Xanthohumol suppresses inflammatory response to warm ischemia-reperfusion induced liver injury.
Dorn C; Massinger S; Wuzik A; Heilmann J; Hellerbrand C
Exp Mol Pathol; 2013 Feb; 94(1):10-6. PubMed ID: 22634733
[TBL] [Abstract][Full Text] [Related]
15. Xanthohumol improved cognitive flexibility in young mice.
Zamzow DR; Elias V; Legette LL; Choi J; Stevens JF; Magnusson KR
Behav Brain Res; 2014 Dec; 275():1-10. PubMed ID: 25192637
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of xanthohumol in rats of both sexes after oral and intravenous administration of pure xanthohumol and prenylflavonoid extract.
Nowak B; Poźniak B; Popłoński J; Bobak Ł; Matuszewska A; Kwiatkowska J; Dziewiszek W; Huszcza E; Szeląg A
Adv Clin Exp Med; 2020 Sep; 29(9):1101-1109. PubMed ID: 32996724
[TBL] [Abstract][Full Text] [Related]
17. Antifeedant activity of xanthohumol and supercritical carbon dioxide extract of spent hops against stored product pests.
Jackowski J; Hurej M; Rój E; Popłoński J; Kośny L; Huszcza E
Bull Entomol Res; 2015 Aug; 105(4):456-61. PubMed ID: 25851834
[TBL] [Abstract][Full Text] [Related]
18. Xanthohumol inhibits cellular proliferation in a breast cancer cell line (MDA-MB231) through an intrinsic mitochondrial-dependent pathway.
Yoo YB; Park KS; Kim JB; Kang HJ; Yang JH; Lee EK; Kim HY
Indian J Cancer; 2014; 51(4):518-23. PubMed ID: 26842182
[TBL] [Abstract][Full Text] [Related]
19. Xanthohumol induces generation of reactive oxygen species and triggers apoptosis through inhibition of mitochondrial electron transfer chain complex I.
Zhang B; Chu W; Wei P; Liu Y; Wei T
Free Radic Biol Med; 2015 Dec; 89():486-97. PubMed ID: 26453927
[TBL] [Abstract][Full Text] [Related]
20. Xanthohumol feeding does not impair organ function and homoeostasis in mice.
Dorn C; Bataille F; Gaebele E; Heilmann J; Hellerbrand C
Food Chem Toxicol; 2010 Jul; 48(7):1890-7. PubMed ID: 20427021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
